“Colloidal silver” (ionic silver solution), though certainly of use for surface infections, has major limitations for the treatment of internal infections. The human body is often imagined as something like a bathtub of water: if you drop a substance into it, it will spread out and automatically go everywhere. In anatomical and physiological reality, the body is extremely compartmentalized and barriered, at every order of anatomical scale—down to the sub-cellular level. Silver ions, just like any medication, do not automatically reach a target area of infection.
CELLULAR BINDING SITES AND INTERNAL ANATOMY PATHWAYS
For colloidal silver solution or spray, there are a million, million molecular binding sites available for the silver ions, starting high up in the gastrointestinal (GI) tract, before they can reach an infection. Additionally, internal pathways are very complex and long. For illustration, the chances of getting a therapeutic dose of silver ions to a kidney infection might be very small. After taking the colloidal silver orally, the silver ions must get through the stomach—where they can bind to the stomach’s hydrochloric acid and be ‘used up’, then go through at least part of GI tract, and eventually find their long anatomical way to the renal (kidney supplying) arteries and into the inner compartments of the infected kidney(s). If they do not pass directly through the walls of the intestines into the bloodstream, they must further be transported out into the circulatory system via the portal venous system route through the liver, into the heart, in and out of the lungs, back to the heart, then back into circulation.
INFLAMMATION HINDERS MEDICATION DELIVERY
Localized inflammation can often limit the delivery of any medication or other substance in general circulation. When inflammatory chemicals are elevated in localized areas of infection or injury, they can cause mechanical, obstructing changes inside and around the small blood vessels (‘arterioles’), and/or these arterioles can become actively vasoconstricted under the control of the smallest (‘group C’) motor (‘efferent’) nerve fibers, resulting in a reduced amount of any medicine delivered via the bloodstream.
THE SIS ELECTROMED TECHNOLOGY
The operation of the SIS machines does not depend on blood flow. Operating on the basic physics of electric voltages, electric currents and conductivity, a constant direct current (DC) is delivered via the shortest possible route, directly to the target infected area.
To read about the SIS machine M250 model for infection treatments, continue to the link below: